The Pharmaceutical and Life Sciences Real World Evidence Market is estimated to be valued at USD 2.30 billion in 2025 and is expected to reach USD 6.19 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.2% from 2025 to 2032. https://timessquarereporter.com/news/pharma---life-sciences-rwe-market-to-surge-with-ai-analytics